Pancreatic Cancer Research

ResearcherTsinghua UniversityActive in the last 2 years

Yongzhang Luo

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-2067-0146; OpenAlex author ID A5101864926. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
6
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: 1 paper · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 4

  1. Correction: Phosphoglycerate dehydrogenase promotes pancreatic cancer development by interacting with eIF4A1 and eIF4E. Last author DOI 10.1186/s13046-024-03252-z↗
  2. Phosphoglycerate dehydrogenase promotes pancreatic cancer development by interacting with eIF4A1 and eIF4E. Last author DOI 10.1186/s13046-019-1053-y↗
  3. Adrenomedullin promotes the growth of pancreatic ductal adenocarcinoma through recruitment of myelomonocytic cells. Last author DOI 10.18632/oncotarget.10393↗
  4. Phase I trial of M2ES, a novel polyethylene glycosylated recombinant human endostatin, plus gemcitabine in advanced pancreatic cancer. Last author DOI 10.3892/mco.2014.271↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xuhui Ma · 3 shared papers, 2016–2024 · strength 0.47
  2. Jie Liu · 2 shared papers, 2019–2024 · strength 0.40
  3. Min Xu · 1 shared paper, 2016 · strength 0.06
  4. Yiqi Du · 1 shared paper, 2014 · strength 0.05
  5. Yang Chen · 1 shared paper, 2014 · strength 0.05
  6. Zhaoshen Li · 1 shared paper, 2014 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.